You are here: Home » Companies » News
Business Standard

Dr Reddy's launches generic arthritis drug Diclofenac Sodium in US market

Dr Reddy's Laboratories on Wednesday said it has launched over-the-counter Diclofenac Sodium topical gel, used for arthritis pain, in the US market

Topics
Dr Reddy's Laboratories

Press Trust of India  |  New Delhi 

medicine, drugs, pharma

Dr Reddy's Laboratories on Wednesday said it has launched over-the-counter Diclofenac Sodium topical gel, used for arthritis pain, in the US market.

The Hyderabad-based company's product is the generic version of Novartis Corporation's Voltaren gel.

"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement.

The company has partnered with Encube Ethicals to bring this product to market for the benefit of consumers, he added.

Diclofenac Sodium topical gel is used for temporary relief of arthritis pain in hand, wrist, elbow, foot, ankle and knee.

According to IRI data, the Voltaren brand had total retail sales of around USD 44 million since launch in May 2020.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Wed, September 09 2020. 13:06 IST
RECOMMENDED FOR YOU